News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Repros Therapeutics Inc. (RPRX) Presents Androxal® and Proellex® Clinical Updates at the Lazard Capital Markets 9th Annual Healthcare Conference



11/14/2012 7:40:58 AM

THE WOODLANDS, Texas, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX)today announced the Company will present clinical updates for both its Androxal® and Proellex® programs this Wednesday, November 14th, at 8 a.m. Eastern time. Due to the format of the conference, the number of slides presented will be abbreviated. The Company is not webcasting the presentation but has the full slide presentation available on its website, www.reprosrx.com. The following significant clinical developments will be discussed in the presentation:

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES